When starting Vitamin B12 therapy, its not unusual for individuals to grapple with questions like, Feeling worse after my B12 injection, is that natural? This period, often termed as a healing crisis, can manifest through symptoms such as: Enhanced feelings of fatigue, tiredness, and increased sleep requirements Sensations akin to mild flu-like symptoms or body aches Experiences of headaches, nausea, or feelings of being lightheaded A foggy mind and challenges with concentration Mood fluctuations including irritability, anxiety, or a subdued mood Alterations in appetite and digestive patterns Contrary to being seen as an adverse reaction, these symptoms are essentially indicative of the body acknowledging and adapting to the surge of B12
Peptide stability after reconstitution is a genuine formulation problem: spray bottles kept at room temperature and used over weeks are likely delivering a partially degraded product, though exact rates are unpublished
These local reactions are common and usually fade in days
Why Retatrutide Combinations Remain Unexplored Unlike cagrilintide, which Novo Nordisk has actively studied in combination with their GLP-1 agonist semaglutide, retatrutide has been developed primarily as a monotherapy by Eli Lilly [11]
Studies show oxidative degradation and peptide aggregation increase beyond this window, reducing bioavailability by 1020% or more depending on storage conditions
